| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Chair | Director
6 companies
Cox Carrie Smith is an Executive Chair at Organon & Co. with holdings across 6 companies. Recent SEC Form 4 filings include 7 buys and 4 sells.
Estimated insider holdings value: $20.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | OGN Organon & Co. | Executive Chair | Buy | 65,400 | $7.67 | $501,755.34 | +524.5% | +1.3% | - | |
| May 14, 2025 | OGN Organon & Co. | Director | Buy | 12,469 | $8.07 | $100,591.16 | New | +12.6% | - | |
| Jul 31, 2023 | TXN Texas Instruments Inc | Director | Sale+OE | 16,055 | $180.04 | $2,890,542.20 | -31.0% | -21.9% | +11.7% | |
| Jun 13, 2022 | RNAC Cartesian Therapeutics, Inc. | Director | Buy | 130,000 | $1.15 | $149,799.00 | +156.9% | +63.4% | +22.3% | |
| Dec 3, 2021 | RNAC Cartesian Therapeutics, Inc. | Director | Buy | 17,200 | $2.95 | $50,664.32 | +26.2% | -40.1% | -54.0% | |
| Oct 23, 2020 | TXN Texas Instruments Inc | Director | Sale+OE | 22,838 | $149.31 | $3,409,978.32 | -40.1% | - | - | |
| Jul 24, 2020 | TXN Texas Instruments Inc | Director | Sale+OE | 26,905 | $130.00 | $3,497,650.00 | -44.1% | - | - | |
| Jun 6, 2019 | ECOR Electrocore, Inc. | Director | Buy | 10,000 | $1.82 | $18,200.00 | +90.9% | - | - | |
| Apr 29, 2019 | TXN Texas Instruments Inc | Director | Sale+OE | 17,002 | $116.08 | $1,973,571.76 | -33.8% | - | - | |
| Dec 3, 2018 | ECOR Electrocore, Inc. | Director | Buy | 7,300 | $6.79 | $49,586.64 | +52.9% | - | - |